Department of Cardiovascular Research, Mario Negri Institute for Pharmacological Research, Milano, Italy.
BMC Med Genet. 2010 Apr 19;11:60. doi: 10.1186/1471-2350-11-60.
A genomic region on chromosome 9p21 has been identified as closely associated with increased susceptibility to coronary artery disease (CAD) and to type 2 diabetes (T2D) although the evidence suggests that the genetic variants within chromosome 9p21 that contribute to CAD are different from those that contribute to T2D.We carried out an association case-control study in an Italian population to test the association between two single nucleotide polymorphisms (SNPs) on the 9p21 locus, rs2891168 and rs10811661, previously reported by the PROCARDIS study, and respectively myocardial infarction (MI) and T2D. Our aim was to confirm the previous findings on a larger sample and to verify the independence of their susceptibility effects: rs2891168 associated with MI but not with T2D and rs10811661 associated with T2D but not with MI.
Genomic DNA samples of 2407 Italians with T2D (602 patients), who had had a recent MI (600), or had both diseases (600) and healthy controls (605) were genotyped for the two SNPs. The genotypes were determined by allelic discrimination using a fluorescent-based TaqMan assay.
SNP rs2891168 was associated with MI, but not with T2D and the G-allele odds ratio (OR) was 1.20 (95% CI 1.02-1.41); SNP rs10811661 was associated with T2D, but not with MI, and the T-allele OR was 1.27 (95% CI 1.04-1.55). ORs estimates from the present study and the PROCARDIS study were pooled and confirmed the previous findings, with greater precision.
Our replication study showed that rs2891168 and rs10811661 are independently associated respectively with MI and T2D in an Italian population. Pooling our results with those reported by the PROCARDIS group, we also obtained a significant result of association with diabetes for rs10811661 in the European population.
染色体 9p21 上的一个基因组区域已被确定为与冠心病 (CAD) 和 2 型糖尿病 (T2D) 的易感性增加密切相关,尽管有证据表明,9p21 染色体上导致 CAD 的遗传变异与导致 T2D 的遗传变异不同。我们在意大利人群中进行了一项关联病例对照研究,以检验 PROCARDIS 研究先前报道的两个位于 9p21 位的单核苷酸多态性 (SNP),rs2891168 和 rs10811661 与心肌梗死 (MI) 和 T2D 之间的关联。我们的目的是在更大的样本中证实先前的发现,并验证它们易感性效应的独立性:rs2891168 与 MI 相关,但与 T2D 无关,而 rs10811661 与 T2D 相关,但与 MI 无关。
对 2407 名意大利人进行了基因分型,这些人患有 T2D(602 例)、近期发生过 MI(600 例)或同时患有这两种疾病(600 例)和健康对照(605 例),这些人都携带两种 SNP。通过荧光基于 TaqMan 测定法进行等位基因鉴别来确定基因型。
SNP rs2891168 与 MI 相关,但与 T2D 无关,G 等位基因比值比 (OR) 为 1.20(95% CI 1.02-1.41);SNP rs10811661 与 T2D 相关,但与 MI 无关,T 等位基因 OR 为 1.27(95% CI 1.04-1.55)。本研究和 PROCARDIS 研究的 OR 估计值被合并,并以更高的精度证实了先前的发现。
我们的复制研究表明,rs2891168 和 rs10811661 分别独立地与意大利人群中的 MI 和 T2D 相关。将我们的结果与 PROCARDIS 小组报告的结果合并,我们还在欧洲人群中获得了 rs10811661 与糖尿病显著相关的结果。